Cargando…

NF1‐mutated melanoma tumors harbor distinct clinical and biological characteristics

In general, melanoma can be considered as a UV‐driven disease with an aggressive metastatic course and high mutational load, with only few tumors (acral, mucosal, and uveal melanomas) not induced by sunlight and possessing a lower mutational load. The most commonly activated pathway in melanoma is t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cirenajwis, Helena, Lauss, Martin, Ekedahl, Henrik, Törngren, Therese, Kvist, Anders, Saal, Lao H., Olsson, Håkan, Staaf, Johan, Carneiro, Ana, Ingvar, Christian, Harbst, Katja, Hayward, Nicholas K., Jönsson, Göran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527484/ https://www.ncbi.nlm.nih.gov/pubmed/28267273 http://dx.doi.org/10.1002/1878-0261.12050

Ejemplares similares

Molecular and genetic diversity in the metastatic process of melanoma
por: Harbst, Katja, et al.
Publicado: (2014)

Molecular stratification of metastatic melanoma using gene expression profiling : Prediction of survival outcome and benefit from molecular targeted therapy
por: Cirenajwis, Helena, et al.
Publicado: (2015)

Loss of CITED1, an MITF regulator, drives a phenotype switch in vitro and can predict clinical outcome in primary melanoma tumours
por: Howlin, Jillian, et al.
Publicado: (2015)

The Role of PTEN Loss in Immune Escape, Melanoma Prognosis and Therapy Response
por: Cabrita, Rita, et al.
Publicado: (2020)

Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
por: Lauss, Martin, et al.
Publicado: (2017)

Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
por: Lauss, Martin, et al.
Publicado: (2020)

DNA methylation subgroups in melanoma are associated with proliferative and immunological processes
por: Lauss, Martin, et al.
Publicado: (2015)

Tumor genetic heterogeneity analysis of chronic sun‐damaged melanoma
por: Sanna, Adriana, et al.
Publicado: (2019)

Analysis of DNA methylation patterns in the tumor immune microenvironment of metastatic melanoma
por: Mitra, Shamik, et al.
Publicado: (2020)

Performance of gene expression–based single sample predictors for assessment of clinicopathological subgroups and molecular subtypes in cancers: a case comparison study in non-small cell lung cancer
por: Cirenajwis, Helena, et al.
Publicado: (2019)

DNA promoter hypermethylation of melanocyte lineage genes determines melanoma phenotype
por: Sanna, Adriana, et al.
Publicado: (2022)

Mutation Screening of 1,237 Cancer Genes across Six Model Cell Lines of Basal-Like Breast Cancer
por: Olsson, Eleonor, et al.
Publicado: (2015)

High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma families
por: Helgadottir, Hildur, et al.
Publicado: (2014)

Improved survival prognostication of node-positive malignant melanoma patients utilizing shotgun proteomics guided by histopathological characterization and genomic data
por: Betancourt, Lazaro Hiram, et al.
Publicado: (2019)

Mutational and gene fusion analyses of primary large cell and large cell neuroendocrine lung cancer
por: Karlsson, Anna, et al.
Publicado: (2015)

Clinical efficacy of T-cell therapy after short-term BRAF-inhibitor priming in patients with checkpoint inhibitor-resistant metastatic melanoma
por: Borch, Troels Holz, et al.
Publicado: (2021)

Qualitative Analysis of Tumor-Infiltrating Lymphocytes across Human Tumor Types Reveals a Higher Proportion of Bystander CD8(+) T Cells in Non-Melanoma Cancers Compared to Melanoma
por: Gokuldass, Aishwarya, et al.
Publicado: (2020)

Distinct gene expression profiles in ovarian cancer linked to Lynch syndrome
por: Jönsson, Jenny-Maria, et al.
Publicado: (2014)

Establishing a Southern Swedish Malignant Melanoma OMICS and biobank clinical capability
por: Welinder, Charlotte, et al.
Publicado: (2013)

Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline CDKN2A mutations
por: Helgadottir, Hildur, et al.
Publicado: (2020)

Participation in a Prospective Cohort Study on Melanoma did not Affect the Incidence and Mortality of the Studied Disease
por: INGVAR, Åsa, et al.
Publicado: (2020)

Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns
por: Holm, Karolina, et al.
Publicado: (2010)

Risk of malignant melanoma in relation to drug intake, alcohol, smoking and hormonal factors.
por: Westerdahl, J., et al.
Publicado: (1996)

Risk of cutaneous malignant melanoma in relation to use of sunbeds: further evidence for UV-A carcinogenicity
por: Westerdahl, J, et al.
Publicado: (2000)

Correlation of histopathologic characteristics to protein expression and function in malignant melanoma
por: Welinder, Charlotte, et al.
Publicado: (2017)

Analysis of Alpha-Synuclein in Malignant Melanoma – Development of a SRM Quantification Assay
por: Welinder, Charlotte, et al.
Publicado: (2014)

Targeted sequencing of BRCA1 and BRCA2 across a large unselected breast cancer cohort suggests that one-third of mutations are somatic
por: Winter, C., et al.
Publicado: (2016)

PTENP1-AS contributes to BRAF inhibitor resistance and is associated with adverse clinical outcome in stage III melanoma
por: Vidarsdottir, Linda, et al.
Publicado: (2021)

Remarkable similarities of chromosomal rearrangements between primary human breast cancers and matched distant metastases as revealed by whole-genome sequencing
por: Tang, Man-Hung Eric, et al.
Publicado: (2015)

A Protein Deep Sequencing Evaluation of Metastatic Melanoma Tissues
por: Welinder, Charlotte, et al.
Publicado: (2015)

B Cells and Tertiary Lymphoid Structures: Friends or Foes in Cancer Immunotherapy?
por: Lauss, Martin, et al.
Publicado: (2022)

An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells
por: Holm, Karolina, et al.
Publicado: (2016)

BRCAsearch: written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer
por: Nilsson, Martin P., et al.
Publicado: (2017)

CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers
por: Olsson, Eleonor, et al.
Publicado: (2011)

Normalization of array-CGH data: influence of copy number imbalances
por: Staaf, Johan, et al.
Publicado: (2007)

Multiple Primary Melanoma Incidence Trends Over Five Decades: A Nationwide Population-Based Study
por: Helgadottir, Hildur, et al.
Publicado: (2020)

Novel functional proteins coded by the human genome discovered in metastases of melanoma patients
por: Sanchez, Aniel, et al.
Publicado: (2019)

Landscape of somatic allelic imbalances and copy number alterations in HER2-amplified breast cancer
por: Staaf, Johan, et al.
Publicado: (2011)

Monitoring of Technical Variation in Quantitative High-Throughput Datasets
por: Lauss, Martin, et al.
Publicado: (2013)

Rapid Identification of the Tumor-Specific Reactive TIL Repertoire via Combined Detection of CD137, TNF, and IFNγ, Following Recognition of Autologous Tumor-Antigens
por: Draghi, Arianna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2tmjoqp2b7mludnrcjgcdchrni